Manufacturer: J B Chemicals and Pharmaceuticals Ltd
Salt Composition : Tirofiban(5mg)
Aggrilek Infusion is administered under the supervision of a doctor. Your doctor will decide the dose and duration of the medicine for you. You should continue all your other medicines that are advised by the doctor for your long term treatment even after this injection. This medicine is used with caution for some people. Before taking it, you must inform the doctor if you are suffering from any bleeding disorder, kidney, or liver disease. Also, let your doctor know if you are breastfeeding and about all the other medications that you are taking regularly.
It works by preventing the platelets from sticking together, thereby decreasing the formation of harmful blood clots. This lowers the chance of heart attack or stroke.
Tirofiban is administered as an intravenous infusion. Volume of distribution ranges from 21 to 87 L, and binding to human plasma proteins is modest at 64%. Metabolism in humans is negligible, and most drug is excreted renally with systemic clearance ranging from 4.8 to 25.8 L/h.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Aggrilek
Headache
Nausea
Hematoma
Ecchymosis (discoloration of the skin resulting from bleeding underneath)
Postoperative bleeding
Blood in stool
Blood in urine
Tirofiban is contraindicated in patients with any of the following: acute pericarditis, intracranial aneurysm, intracranial mass, arteriovenous malformation, any coagulopathy or history of bleeding diathesis within 30 days, severe uncontrolled hypertension (SBP > 180 mmHg and/or DBP > 110 mmHg), recent (within 6 weeks).
Aggrilek Infusion is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
It is not known whether it is safe to consume alcohol with Aggrilek Infusion. Please consult your doctor.
Aggrilek Infusion should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Tirofiban is indicated for the prevention of early myocardial infarction in adult patients presenting with acute coronary syndromes without ST elevation (NSTE-ACS)with the last episode of chest pain occurring within 12 hours and with ECG changes and/or elevated cardiac enzymes.
antiinflammatory drugs, NSAIDs like ibuprofen.
aspirin and aspirin-like medicines.
dipyridamole.
ginkgo.
medicines that treat or prevent blood clots like warfarin, enoxaparin, dalteparin, ticlopidine.
Kindly do not self-administer.
Store below 30°C
If you miss a dose of Aggrilek Infusion, please consult your doctor.
Consult a doctor before taking any medicines.
It increases your risk of bleeding. Be careful while shaving, cutting fingernails or toenails or using sharp objects.
Notify your doctor if you see blood in your vomit, urine or stool (black, tarry stools or bright red blood).
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
Q. Can the use of Aggrilek Infusion increase the risk of bleeding?
Yes, Aggrilek Infusion increases the risk of bleeding. Always be careful while doing activities that may cause an injury or bleeding. Tell your doctor immediately if you notice any abnormal bruising or bleeding.
Q. What medicines should I avoid while taking Aggrilek Infusion?
Aggrilek Infusion can interact with several medicines. Do not take any medicine without talking to your doctor.
Q. When will I feel better after taking Aggrilek Infusion?
Aggrilek Infusion reduces your risk of developing blood clots in the blood vessels of your leg, lungs, heart and brain. You may not feel any difference after taking Aggrilek Infusion. However, keep taking this medicine as prescribed by your doctor because you will still be getting its full benefits.
